Meet the specialists: new types of cancer treatments and their effects Q&A

21st May 2021

Missed our GatewayC Live webinar? Watch the recording here.

In this webinar, GatewayC met Dr Laura Cove-Smith, Consultant in Medical Oncology, and Dr Ahmed Salem, Clinical Senior Lecturer in Lung Cancer Research and Honorary Clinical Oncology Consultant.

Our speakers answered key questions from our audience, which included:

  • What can primary care practitioners do when we see patients with potential side-effects from immunotherapy or radiotherapy?
  • Is there any correlation between the level of toxicity and response to treatment?
  • Are there any red flags for picking up the signs and symptoms of immunotherapy?
  • What has been the impact of COVID-19 on patients undergoing immunotherapy?
  • Should patients undergoing immunotherapy have the COVID-19 vaccine?
  • Is immunotherapy always given as an IV?
  • How useful is the UKONS tool and does this cover the side effects of immunotherapy?
  • How quickly will side-effects occur, for example radiation pneumonitis?
  • Can radiation-induced colitis occur after the completion of radiotherapy?
  • How long after radiotherapy can memory loss occur?

Find our more:

  • Access GatewayC’s full webinar library here
  • Watch this recorded webinar here
  • Access GatewayC’s ‘Managing Physical Effects’ course here

LinkedIn | Twitter | Facebook

Latest from the Blog

Related Posts

New course: Skin Cancer – Early Diagnosis

New course: Skin Cancer – Early Diagnosis

4th May 2022 The GatewayC team are pleased to announce that we have a new course ‘Skin Cancer – Early Diagnosis’ available to all healthcare professionals on GatewayC. Skin cancer is the most common type of cancer and is increasing in incidence in the UK. Skin cancers...

read more
Dr Sarah Taylor’s top picks

Dr Sarah Taylor’s top picks

3rd March 2022 I have listed below my top picks of GatewayC’s online courses and on-demand webinars. I thought this would be helpful if you’re looking to top up your CPD this month. Please do share this email with your colleagues. If they aren’t registered with...

read more